Testing effectiveness (Phase 2)WithdrawnNCT03710941
What this trial is testing
Safety and Efficacy of REGN2477+REGN1033 in Patients With Sporadic Inclusion Body Myositis
Who this might be right for
Sporadic Inclusion Body Myositis
Regeneron Pharmaceuticals